Deferoxamine HCl| CAS# 1950-39-6

MedKoo Cat#: 412109 | Name: Deferoxamine HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Deferoxamine hydrochloride is the hydrochloride salt form of deferoxamine, an iron chelating agent.

Chemical Structure

Deferoxamine HCl

CAS#1950-39-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 412109

Name: Deferoxamine HCl

CAS#: 1950-39-6 (HCl)

Chemical Formula: C25H49ClN6O8

Exact Mass: 0.0000

Molecular Weight: 597.15

Elemental Analysis: C, 50.28; H, 8.27; Cl, 5.94; N, 14.07; O, 21.43

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

70-51-9 (free base) 1950-39-6 (HCl) 138-14-7 (mesylate) 25442-95-9 (hydrate)

Synonym

Deferoxamine hydrochloride; Deferoxamine HCl; Desferal; Ba29837; Ba-29837; Ba 29837; NSC-268993; NSC268993; NSC 268993

IUPAC/Chemical Name

Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy- monohydrochloride

InChi Key

KCRQZLMAZHZDCL-UHFFFAOYSA-N

InChi Code

InChI=1S/C25H48N6O8.ClH/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H

SMILES Code

O=C(N(CCCCCN)O)CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Deferoxamine chelates iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI)

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 597.15 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Yoshimura M, Tamura T, Iida K, Shiota S, Nakayama H, Yoshida S. Hydrogen peroxide causes Vibrio vulnificus bacteriolysis accelerated by sulfonyl fluoride compounds. Arch Microbiol. 2015 Nov;197(9):1075-85. doi: 10.1007/s00203-015-1144-x. Epub 2015 Aug 28. PMID: 26316164. 2: Kim KM, Park SE, Lee MS, Kim K, Park YC. Induction of heme oxygenase‑1 expression protects articular chondrocytes against cilostazol‑induced cellular senescence. Int J Mol Med. 2014 Nov;34(5):1335-40. doi: 10.3892/ijmm.2014.1918. Epub 2014 Aug 29. PMID: 25175370. 3: Hernández-Sánchez A, Tejada-González P, Arteta-Jiménez M. Aluminium in parenteral nutrition: a systematic review. Eur J Clin Nutr. 2013 Mar;67(3):230-8. doi: 10.1038/ejcn.2012.219. Epub 2013 Feb 13. PMID: 23403874. 4: Nuhn P, Mitkus T, Ceyhan GO, Künzli BM, Bergmann F, Fischer L, Giese N, Friess H, Berberat PO. Heme oxygenase 1-generated carbon monoxide and biliverdin attenuate the course of experimental necrotizing pancreatitis. Pancreas. 2013 Mar;42(2):265-71. doi: 10.1097/MPA.0b013e318264cc8b. PMID: 23000891. 5: Ganini D, Canistro D, Jiang J, Stadler K, Mason RP, Kadiiska MB. Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection. Free Radic Biol Med. 2012 Oct 1;53(7):1514-21. doi: 10.1016/j.freeradbiomed.2012.07.013. Epub 2012 Jul 21. Erratum in: Free Radic Biol Med. 2013 Aug;61:10. Jang, JinJie [corrected to Jiang, JinJie]. PMID: 22824865; PMCID: PMC3448871. 6: Huang XP, Thiessen JJ, Spino M, Templeton DM. Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy. Int J Hematol. 2010 Apr;91(3):401-12. doi: 10.1007/s12185-010-0510-3. Epub 2010 Mar 9. PMID: 20213118. 7: Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC. Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol. 2009 Jul;76(1):173-82. doi: 10.1124/mol.109.055137. Epub 2009 Apr 14. PMID: 19366789. 8: Curnow A, Pye A. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors. J Environ Pathol Toxicol Oncol. 2007;26(2):89-103. doi: 10.1615/jenvironpatholtoxicoloncol.v26.i2.40. PMID: 17725535. 9: Cronberg T, Rytter A, Wieloch T. Chelation of intracellular calcium reduces cell death after hyperglycemic in vitro ischemia in murine hippocampal slice cultures. Brain Res. 2005 Jul 5;1049(1):120-7. doi: 10.1016/j.brainres.2005.05.003. PMID: 15935997. 10: Kurz T, Leake A, Von Zglinicki T, Brunk UT. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J. 2004 Mar 15;378(Pt 3):1039-45. doi: 10.1042/BJ20031029. PMID: 14670081; PMCID: PMC1224032. 11: Towner RA, Qian SY, Kadiiska MB, Mason RP. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic Biol Med. 2003 Nov 15;35(10):1330-40. doi: 10.1016/j.freeradbiomed.2003.08.002. PMID: 14607532. 12: Beren J, Hill SL, Diener-West M, Rose NR. Effect of pre-loading oral glucosamine HCl/chondroitin sulfate/manganese ascorbate combination on experimental arthritis in rats. Exp Biol Med (Maywood). 2001 Feb;226(2):144-51. doi: 10.1177/153537020122600213. PMID: 11446439. 13: Nara K, Konno D, Uchida J, Kiuchi Y, Oguchi K. Protective effect of nitric oxide against iron-induced neuronal damage. J Neural Transm (Vienna). 1999;106(9-10):835-48. doi: 10.1007/s007020050204. PMID: 10599866. 14: Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil V, Nadeau R, Rochette L. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem. 1998 Dec;189(1-2):127-35. doi: 10.1023/a:1006945713860. PMID: 9879663. 15: Lai CT, Yu PH. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol. 1997 Feb 7;53(3):363-72. doi: 10.1016/s0006-2952(96)00731-9. PMID: 9065740. 16: Dart RC, Stark Y, Fulton B, Koziol-McLain J, Lowenstein SR. Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA. 1996 Nov 13;276(18):1508-10. PMID: 8903263. 17: Stiles ML, Allen LV Jr, Prince SJ. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Am J Health Syst Pharm. 1996 Jul 1;53(13):1583-8. doi: 10.1093/ajhp/53.13.1583. PMID: 8809281. 18: Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem. 1987 Aug 5;262(22):10438-40. PMID: 3611075. 19: Hachet E. Les cataractes [Cataracts]. Bull Soc Ophtalmol Fr. 1985 Nov;Spec No:87-107. French. PMID: 2866044.